Drug News

Added 11 hours ago Drug news

Ortho Dermatologies re-files Duobrii at FDA as a proposed treatment for psoriasis.

Ortho Dermatologics has resubmitted an application to market its plaque psoriasis lotion Duobrii in the US. The move follows receipt...

Added 1 day ago Drug news

First Phase III trial of sulopenem + probenecid versus ciprofloxacin to treat women with UTI infections.- Iterum Therapeutics.

Iterum Therapeutics plc , announced its initiation of the first of three Phase III clinical trials. In this trial, known...

Added 11 hours ago Drug news

Phase III trial of REGN 475 meets primary endpoint in pain from osteoarthritis of the knee or hip.- Regeneron + Teva.

Regeneron Pharmaceuticals and Teva Pharmaceutical announced positive topline results from a Phase III, randomized, double-blind, placebo-controlled study of REGN 475...

Added 11 hours ago Drug news

Ceftobiprole enters Phase III study for the treatment of patients with bacteremia (bloodstream infections) caused by Staphylococcus aureus.- Basilea Pharma.

Basilea Pharmaceutica Ltd. has announced the start of a clinical phase III study with its antibiotic ceftobiprole. The registration study...

Added 11 hours ago Drug news

FDA approves CEQUA to treat Dry Eye syndrome.- Sun Pharma + Sun Ophthalmics.

Sun Pharmaceutical Industries Ltd. announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the FDA....

Added 1 day ago Drug news

Phase III FREEDOM-EV study shows Orenitram delays disease progression in pulmonary arterial hypertension patients- United Therapeutics

United Therapeutics Corporation announced that preliminary analysis indicates that the FREEDOM-EV clinical study of Orenitram (treprostinil) extended-release tablets in patients...

Added 11 hours ago Drug news

Association of insecticide levels in pregnant women may provide biomarker evidence of a cause of autism according to a new study published in the American Journal of Psychiatry.

Elevated levels of a dichlorodiphenyltrichloroethane (DDT) metabolite in pregnant women provide the first biomarker evidence that the banned insecticide is...

Added 1 day ago Drug news

Phase III ATLAS study success for two-drug regimen ,namely cabotegravir and rilpivirine, for the treatment of HIV compared with continuing a three-drug oral regimen. ViiV HealthCare + Janssen Therapeutics.

ViiV Healthcare announced positive headline results from its global, phase III ATLAS study of a long-acting, injectable two-drug regimen (2DR)...

Added 1 day ago Drug news

FDA approves Kalydeco to treat cystic fibrosis in children aged 12 to <24 months.- Vertex Pharma.

Vertex Pharmaceuticals Incorporated announced the FDA approved Kalydeco (ivacaftor) to include use in children with cystic fibrosis (CF) ages 12...

Added 1 day ago Drug news

FDA approves Jornay PM to treat ADHD symptoms.- Ironshore Pharma & Development Inc.

Ironshore Pharmaceuticals & Development, Inc. a wholly owned subsidiary of Highland Therapeutics Inc. has announced that the FDA has approved...

Search all news articles